Safety and efficacy of tirofiban in preventing neurological deterioration in acute ischemic stroke (TREND): Protocol for an investigator-initiated, multicenter, prospective, randomized, open-label, masked endpoint trial
Jing Wang(Capital Medical University), Chuanhui Li(Capital Medical University), Xunming Ji(Capital Medical University), Wenbo Zhao(Capital Medical University), Sijie Li(Tsinghua–Berkeley Shenzhen Institute), Qingfeng Ma(Capital Medical University), Haiqing Song(Capital Medical University), Chuanjie Wu(Capital Medical University)
Cited by 10
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Transfer of mitochondria from astrocytes to neurons after stroke
|Nature|2016|1.4k
Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2021|899
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Tailoring Rod‐Like FeSe<sub>2</sub> Coated with Nitrogen‐Doped Carbon for High‐Performance Sodium Storage
|Advanced Functional Materials|2018|371